Yuhan Corporation (KRX:000100)

South Korea · Delayed Price · Currency is KRW

69,700

-500 (-0.71%)

Jul 1, 2026, 2:00 PM KST

-32.72% (1Y)

Market Cap	5.24T -32.1%
Revenue (ttm)	2.22T +5.1%
Net Income	209.30B +217.8%
EPS	2,804.37 +214.3%
Shares Out	74.76M
PE Ratio	25.03
Forward PE	37.01
Dividend	500.00 (0.68%)
Ex-Dividend Date	Feb 26, 2026

Volume	193,855
Open	70,900
Previous Close	70,200
Day's Range	68,850 - 71,100
52-Week Range	65,000 - 136,400
Beta	0.39
Analysts	Buy
Price Target	129,222.22 (+85.4%)
Earnings Date	Aug 14, 2026

About Yuhan

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperl... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1926

Employees 2,087

Stock Exchange Korea Stock Exchange

Ticker Symbol 000100

Full Company Profile

Financial Performance

In 2025, Yuhan's revenue was 2.19 trillion, an increase of 5.75% compared to the previous year's 2.07 trillion. Earnings were 191.09 billion, an increase of 170.33%.

Financial Statements

Analyst Summary

According to 18 analysts, the average rating for 000100 stock is "Buy." The 12-month stock price target is ₩129,222, which is an increase of 85.40% from the latest price.

Price Target

₩129,222

(85.40% upside)

Analyst Consensus: Buy

Stock Forecasts